Technical Analysis for ACST - Acasti Pharma, Inc.

Grade Last Price % Change Price Change
grade B 1.91 9.14% 0.16
ACST closed up 9.14 percent on Friday, August 16, 2019, on 72 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical ACST trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Strong but Oversold Other 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Strong, Oversold and Reversal Signs Reversal 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 9.14%
Strong but Oversold Other 9.14%
Wide Bands Range Expansion 9.14%

Older signals for ACST ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for abnormalities in blood lipids, and the treatment and prevention of cardiovascular disorders. The company offers Onemia, a medical food that is used in the dietary management of illnesses associated with omega-3 phospholipids deficiency related to cardiometabolic disorders. Its product development pipeline includes CaPre, a drug product candidate that is in Phase II clinical trial for the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma Inc. is a subsidiary of Neptune Technologies & Bioressources Inc.
Medicine Chemistry Health Biopharmaceutical Cardiovascular Disease Lipid Cardiovascular Disorders Fatty Acids Hypertriglyceridemia Omega 3 Fatty Acid
Is ACST a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.95
52 Week Low 0.44
Average Volume 2,495,684
200-Day Moving Average 1.0835
50-Day Moving Average 1.5948
20-Day Moving Average 2.2115
10-Day Moving Average 2.059
Average True Range 0.253
ADX 37.58
+DI 17.3394
-DI 20.0452
Chandelier Exit (Long, 3 ATRs ) 2.191
Chandelier Exit (Short, 3 ATRs ) 2.189
Upper Bollinger Band 2.7597
Lower Bollinger Band 1.6633
Percent B (%b) 0.23
BandWidth 49.57721
MACD Line 0.082
MACD Signal Line 0.1778
MACD Histogram -0.0958
Fundamentals Value
Market Cap 28.1 Million
Num Shares 14.7 Million
EPS -0.77
Price-to-Earnings (P/E) Ratio -2.48
Price-to-Sales 0.00
Price-to-Book 1.22
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.14
Resistance 3 (R3) 2.12 2.04 2.10
Resistance 2 (R2) 2.04 1.98 2.04 2.08
Resistance 1 (R1) 1.97 1.94 2.01 1.99 2.07
Pivot Point 1.89 1.89 1.90 1.89 1.89
Support 1 (S1) 1.82 1.83 1.86 1.84 1.75
Support 2 (S2) 1.74 1.79 1.74 1.74
Support 3 (S3) 1.67 1.74 1.72
Support 4 (S4) 1.69